arrow_back Back to App

Easier Access to Affordable Biologic Medicines

This act aims to investigate why interchangeable biologic medicines (similar to generic drugs) are not easily available. The goal is to provide citizens with more choices and potentially lower drug prices, which could impact their personal finances and access to treatment.
Key points
Mandates a study to identify barriers preventing the substitution of interchangeable biologic products.
Requires updating the 'Purple Book' list to clarify which biologic products can be safely substituted, potentially leading to more competition and lower prices.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_8877
Sponsor: Rep. Miller-Meeks, Mariannette [R-IA-2]
Process start date: 2022-09-19
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Biologics Competition Act of 2022

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8877.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-09-19.

What are the main provisions?

Key points include:

  • Mandates a study to identify barriers preventing the substitution of interchangeable biologic products.
  • Requires updating the 'Purple Book' list to clarify which biologic products can be safely substituted, potentially leading to more competition and lower prices.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Miller-Meeks, Mariannette [R-IA-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

CATEGORIES

Health